172 related articles for article (PubMed ID: 34804016)
1. The Roles of Transient Receptor Potential Vanilloid 1 and 4 in Pneumococcal Nasal Colonization and Subsequent Development of Invasive Disease.
Kono M; Nanushaj D; Sakatani H; Murakami D; Hijiya M; Kinoshita T; Shiga T; Kaneko F; Enomoto K; Sugita G; Miyajima M; Okada Y; Saika S; Hotomi M
Front Immunol; 2021; 12():732029. PubMed ID: 34804016
[TBL] [Abstract][Full Text] [Related]
2. Cigarette Smoke Attenuates the Nasal Host Response to Streptococcus pneumoniae and Predisposes to Invasive Pneumococcal Disease in Mice.
Shen P; Morissette MC; Vanderstocken G; Gao Y; Hassan M; Roos A; Thayaparan D; Merlano M; Dorrington MG; Nikota JK; Bauer CMT; Kwiecien JM; Labiris R; Bowdish DME; Stevenson CS; Stämpfli MR
Infect Immun; 2016 May; 84(5):1536-1547. PubMed ID: 26930709
[TBL] [Abstract][Full Text] [Related]
3. TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection.
Ellis GT; Davidson S; Crotta S; Branzk N; Papayannopoulos V; Wack A
EMBO Rep; 2015 Sep; 16(9):1203-18. PubMed ID: 26265006
[TBL] [Abstract][Full Text] [Related]
4. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice.
Nakamura S; Davis KM; Weiser JN
J Clin Invest; 2011 Sep; 121(9):3657-65. PubMed ID: 21841308
[TBL] [Abstract][Full Text] [Related]
5. Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation.
Stroo I; Zeerleder S; Ding C; Luken BM; Roelofs JJTH; de Boer OJ; Meijers JCM; Castellino FJ; van 't Veer C; van der Poll T
Thromb Haemost; 2017 Jul; 117(8):1601-1614. PubMed ID: 28492700
[TBL] [Abstract][Full Text] [Related]
6. Synergism and Antagonism of Bacterial-Viral Coinfection in the Upper Respiratory Tract.
Manna S; McAuley J; Jacobson J; Nguyen CD; Ullah MA; Sebina I; Williamson V; Mulholland EK; Wijburg O; Phipps S; Satzke C
mSphere; 2022 Feb; 7(1):e0098421. PubMed ID: 35044807
[TBL] [Abstract][Full Text] [Related]
7. A Murine Model for Enhancement of Streptococcus pneumoniae Pathogenicity upon Viral Infection and Advanced Age.
Joma BH; Siwapornchai N; Vanguri VK; Shrestha A; Roggensack SE; Davidson BA; Tai AK; Hakansson AP; Meydani SN; Leong JM; Bou Ghanem EN
Infect Immun; 2021 Jul; 89(8):e0047120. PubMed ID: 34031128
[TBL] [Abstract][Full Text] [Related]
8. Type I Interferon Signaling Is a Common Factor Driving Streptococcus pneumoniae and Influenza A Virus Shedding and Transmission.
Zangari T; Ortigoza MB; Lokken-Toyli KL; Weiser JN
mBio; 2021 Feb; 12(1):. PubMed ID: 33593970
[TBL] [Abstract][Full Text] [Related]
9. Inflammation as a Modulator of Host Susceptibility to Pulmonary Influenza, Pneumococcal, and Co-Infections.
Aguilera ER; Lenz LL
Front Immunol; 2020; 11():105. PubMed ID: 32117259
[TBL] [Abstract][Full Text] [Related]
10. Innate immune responses at the asymptomatic stage of influenza A viral infections of Streptococcus pneumoniae colonized and non-colonized mice.
Cuypers F; Schäfer A; Skorka SB; Surabhi S; Tölken LA; Paulikat AD; Kohler TP; Otto SA; Mettenleiter TC; Hammerschmidt S; Blohm U; Siemens N
Sci Rep; 2021 Oct; 11(1):20609. PubMed ID: 34663857
[TBL] [Abstract][Full Text] [Related]
11. IL-17 signalling restructures the nasal microbiome and drives dynamic changes following Streptococcus pneumoniae colonization.
Ritchie ND; Ijaz UZ; Evans TJ
BMC Genomics; 2017 Oct; 18(1):807. PubMed ID: 29058583
[TBL] [Abstract][Full Text] [Related]
12. IL-1 Signaling Prevents Alveolar Macrophage Depletion during Influenza and
Bansal S; Yajjala VK; Bauer C; Sun K
J Immunol; 2018 Feb; 200(4):1425-1433. PubMed ID: 29311363
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza.
Mimura K; Kimura S; Kajiwara C; Nakakubo S; Schaller MA; Ishii Y; Standiford TJ; Kunkel SL; Tateda K
Microbes Infect; 2020 Sep; 22(8):312-321. PubMed ID: 31958572
[TBL] [Abstract][Full Text] [Related]
14. Experimental Human Challenge Defines Distinct Pneumococcal Kinetic Profiles and Mucosal Responses between Colonized and Non-Colonized Adults.
Nikolaou E; Jochems SP; Mitsi E; Pojar S; Blizard A; Reiné J; Solórzano C; Negera E; Carniel B; Soares-Schanoski A; Connor V; Adler H; Zaidi SR; Hales C; Hill H; Hyder-Wright A; Gordon SB; Rylance J; Ferreira DM
mBio; 2021 Jan; 12(1):. PubMed ID: 33436429
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the complement C5a receptor alleviates the severity of acute pneumococcal otitis media following influenza A virus infection in mice.
Tong HH; Lambert G; Li YX; Thurman JM; Stahl GL; Douthitt K; Clancy C; He Y; Bowman AS
PLoS One; 2014; 9(4):e95160. PubMed ID: 24740152
[TBL] [Abstract][Full Text] [Related]
16. Lower Density and Shorter Duration of Nasopharyngeal Carriage by Pneumococcal Serotype 1 (ST217) May Explain Its Increased Invasiveness over Other Serotypes.
Bricio-Moreno L; Chaguza C; Yahya R; Shears RK; Cornick JE; Hokamp K; Yang M; Neill DR; French N; Hinton JCD; Everett DB; Kadioglu A
mBio; 2020 Dec; 11(6):. PubMed ID: 33293378
[No Abstract] [Full Text] [Related]
17. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
[TBL] [Abstract][Full Text] [Related]
18. Alternaria alternata challenge at the nasal mucosa results in eosinophilic inflammation and increased susceptibility to influenza virus infection.
Ma M; Redes JL; Percopo CM; Druey KM; Rosenberg HF
Clin Exp Allergy; 2018 Jun; 48(6):691-702. PubMed ID: 29473965
[TBL] [Abstract][Full Text] [Related]
19. Glycolytic Metabolism Is Critical for the Innate Antibacterial Defense in Acute
Fan F; Ma Y; Ai R; Ding Z; Li D; Zhu Y; He Q; Zhang X; Dong Y; He Y
Front Immunol; 2021; 12():624775. PubMed ID: 33953708
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 4 agonistic antibody promotes innate immunity against severe pneumonia induced by coinfection with influenza virus and Streptococcus pneumoniae.
Tanaka A; Nakamura S; Seki M; Fukudome K; Iwanaga N; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
Clin Vaccine Immunol; 2013 Jul; 20(7):977-85. PubMed ID: 23637040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
